Main Logo

Uromigos Live 2024 Perioperative UC Panel Part 2: Adjuvant, Neoadjuvant Therapy and ctDNA Analysis in MIBC After NIAGARA Trial

By Thomas Powles, MBBS, MRCP, MD, Andrea B. Apolo, MD, Shilpa Gupta, MD, Petros Grivas, MD, PhD, Kala Sridhar, MD - Last Updated: October 14, 2024

Tom Powles, MBBS, MRCP, MD, continues the panel session with Andrea Apolo, MD; Petros Grivas, MD, PhD; Shilpa Gupta, MD; and Kala Sridhar, MD, on ctDNA analysis post NIAGARA in MIBC.

Watch the second part of this panel: Neoadjuvant ADC/PD-L1 Combinations, TAR-200, and Bladder-Sparing Approaches in MIBC

Post Tags:Uromigos Live 2024: Focus on Bladder Cancer